<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03196050</url>
  </required_header>
  <id_info>
    <org_study_id>TeleGraPH</org_study_id>
    <nct_id>NCT03196050</nct_id>
  </id_info>
  <brief_title>Telemonitoring of Geriatric Cancer Patients Using Handheld Devices</brief_title>
  <official_title>Telemonitoring of Geriatric Cancer Patients Using Handheld Devices (TeleGraPH)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsmedizin Mannheim</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>H.W. &amp; J. Hector Foundation Weinheim</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>humediQ global GmbH, Grünwald</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Vitaphone GmbH, Mannheim</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitätsmedizin Mannheim</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cancer is becoming a chronic disease, with the requirement of a lifelong intake of
      cancer-controlling drugs. While young(er) patients may cope with this, geriatric cancer
      patients may require a more customized and tailored follow up.

      Most elderly patients have multiple other diseases (&quot;comorbidities&quot;) and, due to many other
      factors, may per se not tolerate or simply not follow anticancer therapies. This may not only
      impair quality of life (QoL), but on the long rung also the therapeutic outcome (survival).

      Handheld devices provide a new reporting/communication tool for patients and health care
      providers. TeleGraPH will assess if these devices are a suitable communication modality in a
      cohort of geriatric cancer patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 2016</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Device Adherence/Compliance</measure>
    <time_frame>1 Year</time_frame>
    <description>Frequency of using the handheld device and of daily/weekly/monthly reportings</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>1 Year</time_frame>
    <description>Assessed using the EORTC QLQ-C30 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reliability of reports</measure>
    <time_frame>1 Year</time_frame>
    <description>Patient-reported status will be compared to physician-rated status</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Cancer</condition>
  <arm_group>
    <arm_group_label>Telemonitoring using a handheld device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will be euqipped with either an app or a handheld device with a pre-installed app to communicate with the coordinating center.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Handheld Device (Smart Phone)</intervention_name>
    <description>Handheld device will be used for 3 tasks:
1x per day: status update (&quot;how are you today&quot;?)
1x per week: 10 questions on general health status
1x per month: EORTC QLQ-C30 questionnaire</description>
    <arm_group_label>Telemonitoring using a handheld device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 60 years

          -  Karnofsky Performance Status ≥ 70

          -  histologically confirmed malignant tumor (cancer)

        Exclusion Criteria:

          -  concurrent severe and/or uncontrolled concomitant medical conditions

          -  Patients unwilling or unable to comply with using a handheld device
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Radiotherapy University Hospital Mannheim</name>
      <address>
        <city>Mannheim</city>
        <zip>68167</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anke Keller, MSc</last_name>
      <phone>00496213834960</phone>
      <email>Studien.Strahlen@medma.uni-heidelberg.de</email>
    </contact>
    <investigator>
      <last_name>Frank A Giordano, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 20, 2017</study_first_submitted>
  <study_first_submitted_qc>June 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 22, 2017</study_first_posted>
  <last_update_submitted>June 20, 2017</last_update_submitted>
  <last_update_submitted_qc>June 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitätsmedizin Mannheim</investigator_affiliation>
    <investigator_full_name>Frederik Wenz</investigator_full_name>
    <investigator_title>Director and Chief Medical Officer</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

